Treatment outcomes | Total patients (n = 165) |
---|---|
End of treatment outcomes (n, %) | |
Treatment success at end of treatment | 144 (87.3) |
Treatment non-completion | 13 (7.8) |
Death | 6 (3.6) |
Failure | 2 (1.2) |
Treatment outcomes in follow-up (n,%) | |
Relapse | 4 (2.4) |
Acquired drug resistance | 0 (0) |
Primary study outcomes | |
Successful outcomea | 140 (84.8%) |
Microbiologically confirmed unsuccessful outcomeb | 12 (7.2%) |